Díte P, Kunovská M, Pulgretová D, Woznica V, Petrtýl J, Hůlek P, Pásková J, Dostalík Z, Novotný I, Procházka V, Hegyi P, Zelenková J, Samek M, Králová Z, Vyhnálek P, Matejovic F, Weinberg J, Kyzeková J
Interni gastroenterologická klinika FN Brno.
Vnitr Lek. 2002 Oct;48(10):976-80.
Effective eradication regimes of Helicobacter pylori infections are nowadays based on administration of a substance with a strong suppressive effect on production of gastric HCl combined with two antibiotics. As suppressor of gastric HCl production unequivocally some drug from the group of proton pump blockers is used. As to antibiotics, in first line therapy the following are recommended: clarithromycin, amoxicillin, metronidazole. A problem in the eradication therapy of Helicobacter pylori infection in recent years is the increasing resistance to clarithromycin and apparently also metronidazole. In the Czech Republic the resistance to clarithromycin in relation to Helicobacter pylori is stabilized at a level lower than 3.0 %. Resistance to metronidazole was reported in 1992 within the range of 24 % - 26 %, however in 2001 it was already 36.0 %. Therefore the question arises whether it is possible under our conditions to check the increasing metronidazole resistance by a drug which by its spectrum of action resembles metronidazole while it differs from it as to its chemical structure. This is the reason why the authors implemented a trial where metronidazole was replaced by tinodazole (Avrazor, Léciva Co.). The results revealed that in the group treated with tinidazole eradication was achieved after 7-day administration of ornidazole in 93.0 %, in the group where part of the eradication regime was metronidazole eradication was 82.6 %. The tolerance of both drugs was very good. The authors recommend to include the pattern omeprazole 2 x 20 mg, clarithromycin 2 x 500 mg and tinidazole 2 x 500 mg among first line therapeutic regimes.
如今,幽门螺杆菌感染的有效根除方案是基于使用一种对胃内盐酸分泌有强烈抑制作用的物质,再联合两种抗生素。作为胃内盐酸分泌的抑制剂,明确会使用质子泵阻滞剂类药物中的一种。至于抗生素,一线治疗推荐使用以下几种:克拉霉素、阿莫西林、甲硝唑。近年来,幽门螺杆菌感染根除治疗中的一个问题是对克拉霉素以及显然还有甲硝唑的耐药性不断增加。在捷克共和国,幽门螺杆菌对克拉霉素的耐药率稳定在低于3.0%的水平。1992年报告的甲硝唑耐药率在24% - 26%之间,但在2001年已达36.0%。因此,问题就出现了,在我们的条件下,是否有可能用一种作用谱与甲硝唑相似但化学结构不同的药物来遏制甲硝唑耐药性的增加。这就是作者开展一项试验的原因,在试验中用替硝唑(Avrazor,Léciva公司)替代甲硝唑。结果显示,在接受替硝唑治疗的组中,服用奥硝唑7天后根除率为93.0%,而在根除方案中部分使用甲硝唑的组中,根除率为82.6%。两种药物的耐受性都非常好。作者建议将奥美拉唑2×20毫克、克拉霉素2×5毫克和替硝唑2×5毫克的用药方案纳入一线治疗方案中。